Head and neck squamous cell carcinomas (HNSCCs) refers to a group of highly malignant
and pathogenically complex tumors. Traditional treatment methods include surgery …

Head and neck squamous cell carcinoma (HNSCC) originates from the squamous
epithelium of the oral cavity, oropharynx, larynx, and hypopharynx. HNSCC in the oral cavity …

Immunotherapies such as immune checkpoint blockade benefit only a portion of patients
with head and neck squamous cell carcinoma. The multidisciplinary field of nanomedicine is …

Head and neck cancers are a heterogeneous group of highly aggressive tumors and
collectively represent the sixth most common cancer worldwide. Most head and neck …

OSCC (oral squamous cell carcinoma) is currently one of the most formidable cancers
plagued by challenges like low overall survivability, lymph node associated metastasis, drug …

The tumor microenvironment (TME) has drawn considerable research attention as an
alternative target for nanomedicine-based cancer therapy. Various nanomaterials that carry …

Nanomaterials (NMs) have increasingly been used for the diagnosis and treatment of head
and neck cancers (HNCs) over the past decade. HNCs can easily infiltrate surrounding …

Interaction between the tumor microenvironment (TME) and tumor cells can promote
disease progression. Understanding the biological make-up of head-and-neck squamous …

Head and neck squamous cell cancer (HNSCC) is one of the ten most common malignant
neoplasms, characterized by an aggressive course, high recurrence rate, poor response to …

Head and Neck Squamous Cell Carcinoma (HNSCC) is categorized as the sixth most
common cancer worldwide, with an incidence of more than 830,000 cases per year and a …